These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1671646

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
    Suzuki E, Kanba S, Nibuya M, Adachi S, Sekiya U, Shintani F, Kinoshita N, Yagi G, Asai M.
    Biol Psychiatry; 1994 Nov 15; 36(10):654-61. PubMed ID: 7880934
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma HVA, neuroleptics, and dopaminergic plasticity.
    Dávila R.
    Biol Psychiatry; 1989 Jan 15; 25(1):1-3. PubMed ID: 2563229
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of -141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole.
    Miura I, Kanno-Nozaki K, Hino M, Horikoshi S, Ota T, Mashiko H, Niwa S, Yabe H.
    J Clin Psychopharmacol; 2015 Jun 30; 35(3):333-4. PubMed ID: 25871573
    [No Abstract] [Full Text] [Related]

  • 12. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls.
    Duncan E, Bollini AM, Sanfilipo M, Wieland S, Angrist B, Cooper TB, Rotrosen J.
    Schizophr Res; 2006 Jan 31; 81(2-3):323-6. PubMed ID: 16181774
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R, Zumárraga M, Basterreche N, Arrúe A, Anguiano JB.
    Psychiatry Res; 2007 May 30; 151(1-2):163-8. PubMed ID: 17434602
    [Abstract] [Full Text] [Related]

  • 15. Plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity, and psychopathology in chronic schizophrenia.
    Koshikawa H, Suzuki E, Kanba S, Nibuya M, Ishizuki T, Kohno H, Kinoshita N, Shintani F, Yagi G, Nakaki T.
    Yakubutsu Seishin Kodo; 1991 Feb 30; 11(1):79-81. PubMed ID: 1679276
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R, Zumarraga M, Andia I, Friedhoff AJ.
    Life Sci; 1989 Feb 30; 44(16):1117-21. PubMed ID: 2565009
    [Abstract] [Full Text] [Related]

  • 19. Relationship of plasma HVA and treatment response in a large series of patients with schizophrenia.
    Davila R.
    Clin Neuropharmacol; 1992 Feb 30; 15 Suppl 1 Pt A():519A-520A. PubMed ID: 1354057
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.